WallStreetZenWallStreetZen

NASDAQ: ZYBT
Zhengye Biotechnology Holding Ltd Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Zhengye Biotechnology Holding earnings were -$10.2M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest ZYBT earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ZYBT reported annual earnings of -$9.9M, with -739.7% growth.

ZYBT earnings history

Current Revenue
$16.5M
Current Earnings
-$9.9M
Current Profit Margin
-60%

ZYBT Return on Equity

Current Company
-26.1%
Current Industry
13.4%
Current Market
28.9%
ZYBT's Return on Equity (-26.1%)... subscribe to Premium to read more.
High Return on Equity Performance

ZYBT Return on Assets

Current Company
-15%
Current Industry
5.3%
ZYBT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ZYBT announces earnings.

ZYBT Return on Capital Employed

Current Company
-17.5%
Current Industry
11.7%
ZYBT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZYBT vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ZYBT-$4.30M-$10.23MN/A-$0.22
SCYX-$8.44M-$8.61MN/A-$0.17
TLPH-$14.29M-$14.29MN/A-$0.34
INCR-$3.84M-$11.90MN/A-$0.22
RMTI$143.00k-$5.31MN/A-$0.15
View Top Pharmaceutical Stocks

Zhengye Biotechnology Holding Earnings Reports & History FAQ

What were Zhengye Biotechnology Holding's earnings last quarter?

Zhengye Biotechnology Holding (NASDAQ: ZYBT) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total ZYBT earnings for the quarter were N/A. In the same quarter last year, Zhengye Biotechnology Holding's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Zhengye Biotechnology Holding stock.

Is Zhengye Biotechnology Holding profitable or losing money?

As of the last Zhengye Biotechnology Holding earnings report, Zhengye Biotechnology Holding is currently losing money. Zhengye Biotechnology Holding's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$9.91 million, a 739.74% decrease year over year.

What was ZYBT's earnings growth in the past year?

As of Zhengye Biotechnology Holding's earnings date in Q2 2026, Zhengye Biotechnology Holding's earnings has grown year over year. ZYBT earnings in the past year totalled -$10.23 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.